Představujeme vědecké práce autorů z 1. LF UK (na pozici prvního, korespondenčního či seniorního autora), které byly publikovány v časopisech v prvním oborovém decilu (podle impakt faktoru). We present the scientific papers of authors from the First Faculty of Medicine (first, corresponding or senior authors are mentioned) published in journals in the first decile (ranked by Journal Impact Factor).
Koresp. autoři označeni hvězdičkou, autoři z 1. LF tučně. Corresp. authors marked with an asterisk, authors from the 1st Faculty of Medicine in bold.

Honigova K, Hadrava Vanova K, Raudenska M, Uher O, Kejík Z, Jakubek M, Masařík M*, Pacak K*. Block, expose, and immunize: triple attack on cancer. Trends in Molecular Medicine. 2026, 32(2), 108-118. ISSN 1471-4914.
https://doi.org/10.1016/j.molmed.2025.06.009 / UT WoS: 001689702700001 / IF = 13.800 (2024)

Heerspink HJ*, Rovin BH, Komers R, Hendry B, Mercer A, Preciado P, Murphy E, Tesař V. Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 2026, 21(4), 578-592. ISSN 1555-9041.
https://doi.org/10.2215/CJN.0000000961 / UT WoS: 001690324600001 / IF = 7.100 (2024)

Simek M, Tykalova T, Novotny M, Illner V, Kouba T, Subert M, Sovka P, Svihlik J, Růžička E, Šonka K, Dušek P, Rusz J*. Speech Biomarkers From Smartphone Calls Track Progression in REM Sleep Behavior Disorder and Parkinson's Disease. Annals of Neurology. 2026, 99(4), 935-948. ISSN 0364-5134.
https://doi.org/10.1002/ana.78140 / UT WoS: 001650931800001 / IF = 7.700 (2024)

Fischerová D*, Pinto P, Alcazar Zambrano JL, Vara-garcia J, Chiappa V, Raspagliesi F, Franchi D, Urbinati AV, Testa AC, Jarkovsky J, Cibula D, Moro F. Comparison of ultrasound with computed tomography and whole-body diffusion-weighted MRI in prediction of surgical outcome using ESMO-ESGO criteria in patients with tubo-ovarian carcinoma: prospective ISAAC study. Ultrasound in Obstetrics and Gynecology. 2026, 67(2), 207-219. ISSN 0960-7692.
https://doi.org/10.1002/uog.70109 / UT WoS: 001608490400001 / IF = 6.300 (2024)

Sehn LH*, Hubel K, Luminari S, Scholz ChW, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee H, Jimenez-Ubieto A, Sancho J, Kim TM, Domenech ED, Kumode T, Poh Ch, Thieblemont C, Deeren D, de Wit E, Arbushites M, Vassallo I, Trněný M. Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial. The Lancet. 2026, 407(10524), 133-146. ISSN 0140-6736.
https://doi.org/10.1016/S0140-6736(25)01778-7 / UT WoS: 001666281300001 / IF = 88.500 (2024)

další publikace roku (more publications of) 2026

publikace roku (publications of) 2025

publikace roku (publications of) 2024

publikace roku (publications of) 2023

publikace roku (publications of) 2022

publikace roku (publications of) 2021

publikace roku (publications of) 2020